Anthony A. Lombardo
Director Ejecutivo en E-Z-EM, Inc. .
Origen de la red de primer grado Anthony A. Lombardo.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Extinct | Pharmaceuticals: Major | 7 | |
E-Z-EM, Inc.
 E-Z-EM, Inc. Medical SpecialtiesHealth Technology E-Z-EM, Inc. develops, manufactures and markets diagnostic imaging products. The firm's products are used for computed tomography and magnetic resonance imaging, colorectal cancer screening, evaluation of swallowing disorders and testing for other diseases, and disorders of the gastrointestinal system. The company was founded in 1961 and is headquartered in Lake Success, NY.
1
| Subsidiary | Medical Specialties | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Anthony A. Lombardo a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Medical/Nursing Services | Chief Executive Officer General Counsel | |
| Dickinson Law School | College/University | Graduate Degree Graduate Degree | |
| ADVAXIS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| AYALA PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| St. John's University | College/University | Undergraduate Degree | |
| SYNEOS HEALTH, INC. | Biotechnology | General Counsel | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ONCOLYTICS BIOTECH INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Sellas Life Sciences Group Ltd.
 Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Universidad Nacional Autónoma de México | College/University | Doctorate Degree | |
| SONOMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| AMBRX INC | Pharmaceuticals: Major | Chief Executive Officer | |
inVentiv Health Clinical, Inc.
 inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health Clinical, Inc. provides clinical research and drug development services. It provides its services to the pharmaceutical, biotechnology, generic drug, and medical device industries. The firm offers clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical development programs. The company was founded in 1984 and is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Chief Executive Officer | |
Instituto Nacional de Ciencias Medicas y Nutricion
 Instituto Nacional de Ciencias Medicas y Nutricion Hospital/Nursing ManagementHealth Services Instituto Nacional de Ciencias Medicas y Nutricion operates hospitals. The private company is based in Mexico City, Mexico. | Hospital/Nursing Management | Corporate Officer/Principal | |
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Pharmaceuticals: Major | Director/Board Member | |
| Usmc Officer Candidates School | College/University | Undergraduate Degree | |
| ZYVERSA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Biotechnology | Founder | |
| Boston University | College/University | Undergraduate Degree | |
| Larkspur Health LLC | Founder | ||
| SEELOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | General Counsel | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Merck Sharp & Dohme Corp.
 Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Delaware | College/University | Graduate Degree | |
| CELGENE | Biotechnology | Corporate Officer/Principal | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Curate Biosciences
 Curate Biosciences Miscellaneous Commercial ServicesCommercial Services Curate Biosciences engages in the development of a liquid biopsy platform for obtaining rare circulating tumor cells. It offers a desktop fluidic system for cell separation that pumps blood through a disposable microchip. The company was founded by Michael D. Grisham in 2002 and is headquartered in Richmond, VA. | Miscellaneous Commercial Services | Director/Board Member | |
| Fu Foundation School of Engineering & Applied Science | College/University | Graduate Degree | |
Andelyn Biosciences
 Andelyn Biosciences BiotechnologyHealth Technology Andelyn Biosciences is a full-service cell and gene therapy company that specializes in the development, characterization, and production of viral vectors for gene therapy. The private company is based in Columbus, OH. The company operates out of three facilities in Ohio and offers support to its clients in developing curative cell and gene therapies from concept through plasmid development and manufacturing, process development, and cgmp clinical and commercial manufacturing. Andelyn's advanced digital model, quality system, full regulatory support, and supply chain vertical integration help accelerate the development and manufacturing of its clients' innovative cell and gene therapies. The company has more than 20 years of experience and has produced cgmp material for over 450 clinical batches and 75 clinical trials. Andelyn's versatile capabilities include cgmp manufacturing capacity for both adherent and suspension processes up to a 2,000-liter capacity. The CEO of the company is Wade Macedone. | Biotechnology | Chief Executive Officer | |
| ROCKET PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal | |
| Stevens Institute of Technology | College/University | Undergraduate Degree | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
Rosetta Genomics, Inc.
 Rosetta Genomics, Inc. Medical/Nursing ServicesHealth Services Part of Rosetta Genomics Ltd., Rosetta Genomics, Inc. is a company that focuses on targeted therapies for cancer. The company is based in Philadelphia, PA. The company's website provides information about their blog on cancer research and healthy living tips for World Cancer Day. The blog aims to educate people about the challenges of cancer and the need for targeted therapies. The company also participated in World Cancer Day 2015 to raise awareness about the fight against cancer. | Medical/Nursing Services | President | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ortho-Clinical Diagnostics, Inc.
 Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ. | Medical Specialties | Corporate Officer/Principal | |
Veridex LLC
 Veridex LLC Medical SpecialtiesHealth Technology Part of Kenvue, Inc., Veridex LLC is a company that supplies vitro diagnostic oncology products. The company is based in Raritan, NJ. | Medical Specialties | Corporate Officer/Principal | |
| UCLA School of Law | College/University | Graduate Degree | |
| NEWELL BRANDS INC. | Industrial Conglomerates | Corporate Officer/Principal | |
| Princeton University | College/University | Undergraduate Degree | |
| ROSETTA GENOMICS LTD. | Biotechnology | Chief Executive Officer | |
| Instituto Nacional de Salud Pública de México | Corporate Officer/Principal |
Estadísticas
Internacional
| Estados Unidos | 43 |
| México | 4 |
| Israel | 3 |
| Canadá | 2 |
| Bermudas | 2 |
Sectorial
| Health Technology | 29 |
| Consumer Services | 11 |
| Health Services | 4 |
| Commercial Services | 4 |
| Finance | 3 |
Operativa
| Director/Board Member | 43 |
| Corporate Officer/Principal | 24 |
| Chief Executive Officer | 14 |
| President | 13 |
| Chief Tech/Sci/R&D Officer | 11 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Thomas Ridge | 49 |
| Daniel O'Connor | 22 |
| Andres Gutiérrez | 13 |
| Ken Berlin | 11 |
| Mayo Pujols | 11 |
| Robert W. Ashworth | 7 |
| Thomas W. Hare | 2 |
| Sandra D. Baron | 1 |
- Bolsa de valores
- Insiders
- Anthony A. Lombardo
- Conexiones Empresas
